相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatic Knockdown of Endothelin Type A Receptor (ETAR) Ameliorates Hepatic Insulin Resistance and Hyperglycemia Through Suppressing p66Shc-Mediated Mitochondrial Fragmentation in High-Fat Diet-Fed Mice
Li Feng et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Plasma adrenomedullin level and year-by-year variability of body mass index in the general population
Johji Kato et al.
PEPTIDES (2021)
Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes
Valborg Gudmundsdottir et al.
DIABETES (2020)
Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study
Chaterina Sujana et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Endothelin-1 in the pathophysiology of obesity and insulin resistance
Haley N. Jenkins et al.
OBESITY REVIEWS (2020)
Midregional proadrenomedullin predicts reduced blood pressure and glucose elevation over time despite enhanced progression of obesity markers
Therese Ohlsson et al.
JOURNAL OF HYPERTENSION (2019)
Endothelin: 30 Years From Discovery to Therapy
Matthias Barton et al.
HYPERTENSION (2019)
Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population
Navin Suthahar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
Anubha Mahajan et al.
NATURE GENETICS (2018)
Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes
Silvia Bonas-Guarch et al.
NATURE COMMUNICATIONS (2018)
Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells
Takahiro Horinouchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Endothelin-1 as a predictor of impaired glucose tolerance and type 2 diabetes - A longitudinal study in the Vara-Skovde Cohort
Josefin Olausson et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2016)
mice: Multivariate Imputation by Chained Equations inR
Stef van Buuren et al.
Journal of Statistical Software (2015)
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries
Tanja Zeller et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Endothelin and endothelin antagonists in chronic kidney disease
Donald E. Kohan et al.
KIDNEY INTERNATIONAL (2014)
Genome-Wide Association Study on Plasma Levels of Midregional-Proadrenomedullin and C-Terminal-Pro-Endothelin-1
Niek Verweij et al.
HYPERTENSION (2013)
Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study
Jochen Seissler et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Endothelin-1 Reduces Glucose Uptake in Human Skeletal Muscle In Vivo and In Vitro
Alexey Shemyakin et al.
DIABETES (2011)
Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization
Christopher F. MacManus et al.
FASEB JOURNAL (2011)
Endothelin-1 Suppresses Long-Chain Fatty Acid Uptake and Glucose Uptake Via Distinct Mechanisms in 3T3-L1 Adipocytes
Yueh Chien et al.
OBESITY (2011)
Regulation of Glucose Uptake by Endothelin-1 in Human Skeletal Muscle in Vivo and in Vitro
Alexey Shemyakin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
Veikko Salomaa et al.
PLOS ONE (2010)
Endothelium-derived endothelin-1
Eric Thorin et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis
Vanessa van Harmelen et al.
DIABETES (2008)
The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes
Su Chi Lim et al.
DIABETES CARE (2007)
Adrenomedullin is a novel adipokine: Adrenomedullin in adipocytes and adipose tissues
Yin Li et al.
PEPTIDES (2007)
Endothelin limits insulin action in obese/insulin-resistant humans
Amale Lteif et al.
DIABETES (2007)
Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma
Jana Papassotiriou et al.
CLINICAL CHEMISTRY (2006)
Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism
AB Strawbridge et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Expression of the adrenomedullin gene in adipose tissue
T Nambu et al.
REGULATORY PEPTIDES (2005)
Adrenomedullin - A protective factor for blood vessels
J Kato et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2005)
Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity
C Letizia et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2005)
Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice
LL Yang et al.
CIRCULATION (2004)
Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress
T Shimosawa et al.
HYPERTENSION (2003)
Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with type 2 diabetes
A Katsuki et al.
DIABETES CARE (2003)
Regulation of pancreatic physiology by adrenomedullin and its binding protein
E Zudaire et al.
REGULATORY PEPTIDES (2003)
Endothelin-1 stimulates leptin production in adipocytes
YM Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
